Switch to:
More From Other Websites
What Are Analysts’ Recommendations for Regeneron in 2016? Aug 31 2016
Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns Aug 31 2016
Pfizer’s Medivation Acquisition: What You Need to Know Aug 23 2016
Ozanimod May Prove to Be a Strong Growth Driver for Celgene Aug 18 2016
These Concerns Affected Gilead’s Change in Full-Year Guidance Aug 02 2016
Vertex’s Orkambi to Treat Cystic Fibrosis Drives Company’s Growth Aug 01 2016
BioMarin: Why So Many ‘Buy’ Recommendations? Jul 31 2016
Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016? Jul 08 2016
Understanding the Valuation Catalysts for BioMarin in 4Q16 Jul 06 2016
Hunting for value Jul 01 2016
Deutsche Balaton AG :BBH-DE: Earnings Analysis: For the six months ended December 31, 2015 : June... Jun 29 2016
Which Biotechnology Companies Could Benefit from Brexit? Jun 28 2016
As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs Jun 23 2016
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead May 17 2016
What Lies Ahead for Biotech ETFs? May 13 2016
Will the Current Pipeline Help Medivation Go beyond Xtandi? May 12 2016
The Story behind Medivation’s Rising Collaboration Revenue May 11 2016
A Promising Uptake for Vertex’s Orkambi May 04 2016
Biotech ETFs Sink on Mixed Q1 Results May 02 2016
2 Dirt-Cheap Big Pharma Stocks Poised to Beat Biotech's Bad Rap May 02 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK